| Name | Title | Contact Details |
|---|
For more than 20 years, Fortus Healthcare Resources has embraced a personalized approach to recruiting. With a candidate database unmatched in the industry, we value our relationship with clients and candidates. The Fortus Group is the pioneer of dialysis recruitment. Since 1993, we have been committed to providing recruitment solutions for the dialysis industry with much success and growth. Our organization has expanded from a one-desk specialty recruiter to a state-of-the-art facility. With a staff of over 30, we continue to maintain the largest recruiting staff industrywide. Our company`s 100+ years combined dialysis recruiting experience enables us to provide the best possible means for candidates to fulfill their goals. In 2006, our services expanded from permanent placement of dialysis and transplantation professionals to the placement of travel nurses. With flexible, competitive salary and benefit packages, Fortus Group Travel offers the healthcare industry temporary staffing relief, while providing nurses with unlimited travel opportunities. The Fortus Group continues to build on its strong foundation of quality resources and dedicated relationships. The success of our company is based on bringing together the highest quality career consultants dedicated to providing outstanding opportunities to our specialized industry.
Waldorf Technik is a Saint Charles, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
Ascent Living Communities is a company that operates senior living communities in Colorado, offering independent living, assisted living, and memory care services.
Biopro Implants is a Port Huron, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.